Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • Services & Support
  • Cart
  • Transplant Indications and Outcomes
    • HLA Today
    • Disease-Specific Indications and Outcomes
      • AML - Adult
      • AML - Pediatric
      • ALL - Adult
      • ALL - Pediatric
      • Myelodysplastic Syndromes (MDS)
      • CML
      • CLL
      • NHL
      • Hodgkin Lymphoma
      • Multiple Myeloma
      • Severe Aplastic Anemia & Marrow Failure
      • Sickle Cell Disease
      • Immune Deficiency Diseases
      • Inherited Metabolic Disorders
      • Thalassemia
      • Other Diseases
      • Myeloproliferative Neoplasms
    • Additional Outcomes
      • Unrelated vs. Sibling Donor Outcomes
      • Older Patient Outcomes
      • Timing Impact on Outcomes
    • Eligibility
    • Referral Timing Guidelines
    • Order Kits
    • HLA Typing for Family Members
  • Transplant Therapy and Donor Matching
    • Cell Sources
    • HLA Typing and Matching
    • Donor or Cord Blood Search Process
      • Likelihood of Finding a Match
      • Preliminary Search Request
    • Jason Carter Clinical Trials Program
  • Post-Transplant Care
    • Early Complications
    • Vaccinations
    • Long-Term Care Guidelines
      • Pediatric Considerations
    • Chronic GVHD
      • Skin
      • Nails
      • Scalp and Body Hair
      • Eyes
      • Mouth
      • Lungs
      • Muscles, Fascia, Joints
      • Hematopoietic & Immune
      • GI Tract
      • Liver
      • Genitalia
      • Other
    • Post-Transplant Guidelines
  • Medical Education & Research
    • Browse News
      • Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
    • Browse Research
    • Education Catalog
      • HLA and Search Strategy Resources
      • GVHD Interactive Provider Network Virtual Learning Series
    • Materials Catalog
    • HCT Presentation Slides
    • About Our Research
    • Transplant Enews
  • Resources
    • Patient Resources
    • Financial Resources
    • Obstetrician Resources
    • Technique Videos
    • Umbilical Cord Blood Collection Training for Public Donation
    • Local Provider Partnership Program

About Us

  • What We Do
  • Our History
  • Leadership
  • Careers
  • Privacy Policy
  • Support & Services
  • About Us
  • Our History
  • Email
  • Print This Page

Our History

The National Marrow Donor Program® (NMDP)/Be The Match®, is a nonprofit organization that facilitates transplants for patients in need of a hematopoietic cell transplant (HCT). We operate the Be The Match Registry®, support patients, educate health care professionals, and conduct research. From very humble beginnings and a hope to serve, to where we are today, our dedication for saving lives has never wavered. Our story started in 1979.

A Story Born of Love for a Child

When their 10-year-old daughter Laura was diagnosed with leukemia, Robert Graves, D.V.M., and his wife Sherry were ready to do anything they could to save her. Desperate to save her life, they turned to alternative treatment options and Laura became the first ever patient with leukemia to undergo a bone marrow transplant from an unrelated donor.

Laura received her transplant in September 1979, and the donated cells engrafted in her body without complications. Laura survived for two years after her transplant, but she sadly died from a relapse of her leukemia. But her initial complete recovery established that unrelated donor marrow transplantation was feasible, which inspired Laura's family to give other families the same hope for a cure. Thanks to Sherry and Dr. Graves, other patient families, doctors, congressional support, and funding from the United States Navy, a national registry of volunteers willing to donate bone marrow was born in 1986.

The First 10,000 Platelet Donors Step Forward

At the time, many people doubted that enough people would be willing to donate marrow to a stranger. With this in mind, the early founders of our program focused on recruiting platelet donors because of their demonstrated altruism and because they were already HLA-A and -B tissue typed. This proved to be a successful strategy, and within the first year the National Bone Marrow Donor Registry (as we were called then) was established, an astonishing 10,000 platelet donors answered the call. We conducted our first transplant in December 1987 when Diane Walters of Wisconsin donated marrow to 6-year-old Brooke Ward of North Carolina. The next year, we changed our name to the National Marrow Donor Program® (NMDP), and it wasn't long before the NMDP took off worldwide from a tiny office at the American Red Cross in St. Paul, Minnesota.

Investing in Research

Beyond establishing the registry, we also decided to conduct research to expand treatment options and find the answers that would save the lives of more patients and improve their quality of life.

  • 1990 - Nobel Prize in Medicine awarded to Dr. E. Donnall Thomas for discoveries in cellular transplantation
  • 1997 - First use of peripheral blood stem cells in NMDP transplants
  • 1998 - The NMDP launches its umbilical cord blood transplant program
  • 2001 - Built the NMDP Sample Repository, one of the world's largest tissue sample storage facilities used for medical research
  • 2004 - Partnered with the Medical College of Wisconsin to create our research program, the CIBMTR® (Center for International Blood and Marrow Transplant Research®)
  • 2012 - Completed more than 700 peer-reviewed publications based on research conducted
  • 2013 - Facilitated more than 2,800 transplants for patients over age 50 (45% of total transplants)
  • 2016 - Launched Be The Match BioTherapies® to extend our services and expertise to organizations developing and delivering cellular therapies to help more patients

Leading the Way - Now and Into the Future

Today, we have facilitated more than 80,000 hematopoietic cell transplants with marrow, PBSC, and cord blood, and now conduct nearly 6,200 transplants a year.

As the recognized leader in unrelated hematopoietic cell transplantation, we develop services and interactive technologies used by transplant experts around the world to reach more patients.

We continue making history in cellular therapies, advancing services to speed the transplant process and improving treatments for post-transplant complications. We invest in research and work with researchers who dedicate countless volunteer hours so that more patients than ever before can receive a transplant and have significantly improved long-term survival and quality of life.

  • Email
  • Print This Page

Slides may be downloaded and used without permission for one-time presentation or personal use.  For publication, use in print or web, or repeated presentations, please submit a Copyright Request Form.

Keep In Touch

  • Contact Us
  • Transplant Enews

Our Websites

  • Be The Match
  • Be The Match Mexico
  • Be The Match BioTherapies
  • CIBMTR
  • Jason Carter Clinical Trials Search
National Marrow Donor Program —
Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
Copyright © 1996-2023 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright